The main pathways of TBFS in the treatment of COPD included the AGE-RAGE signaling pathway in diabetic complications, IL-17 signaling pathway, PI3K-Akt signaling pathway, TNF signaling pathway, and MAPK signaling pathway suggesting that the TBFS formula can act through multiple pathways. The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.